Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Rose

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|July 12, 2011
Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environmentKate E Oliver, Lindsey R Enewold, Kangmin Zhu, et al.
Gynecologic Oncology|October 8, 2003
Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpusWilliam E Winter, Jeffrey D Seidman, Thomas C Krivak, et al.
Gynecologic Oncology|November 18, 2005
The prevalence of HR-HPV DNA in ASC-US Pap smears: A military population studyMichael P Stany, Michael A Bidus, Elizabeth J Reed, et al.
Gynecologic Oncology|July 25, 2006
Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group studyJeffrey Bell, Mark F Brady, Robert C Young, et al.
American Journal of Obstetrics and Gynecology|August 5, 2008
Cervical biopsy and excision procedure specimens lack sufficient predictive value for lymph-vascular space invasion seen at hysterectomy for cervical cancerMichael A Bidus, Angela S Caffrey, Whitney B You, et al.
The Lancet. HIV|June 29, 2018
Development and implementation of participant safety plans for international research with stigmatised populationsJeremy Sugarman, Mark Barnes, Scott Rose, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2009
Diffuse laminar endocervical glandular hyperplasia: a case reportLouis A Dainty, Thomas C Krivak, Joel C Webb, et al.
Cancer|September 27, 2006
Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group studyG Larry Maxwell, Chunqiao Tian, John Risinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group StudyWilliam E Winter, G Larry Maxwell, Chunqiao Tian, et al.
Cancer Research|September 5, 2006
Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancerJan S Sunde, Howard Donninger, Kongming Wu, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|July 12, 2011
Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environmentKate E Oliver, Lindsey R Enewold, Kangmin Zhu, et al.
Gynecologic Oncology|October 8, 2003
Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpusWilliam E Winter, Jeffrey D Seidman, Thomas C Krivak, et al.
Gynecologic Oncology|November 18, 2005
The prevalence of HR-HPV DNA in ASC-US Pap smears: A military population studyMichael P Stany, Michael A Bidus, Elizabeth J Reed, et al.
Gynecologic Oncology|July 25, 2006
Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group studyJeffrey Bell, Mark F Brady, Robert C Young, et al.
American Journal of Obstetrics and Gynecology|August 5, 2008
Cervical biopsy and excision procedure specimens lack sufficient predictive value for lymph-vascular space invasion seen at hysterectomy for cervical cancerMichael A Bidus, Angela S Caffrey, Whitney B You, et al.
The Lancet. HIV|June 29, 2018
Development and implementation of participant safety plans for international research with stigmatised populationsJeremy Sugarman, Mark Barnes, Scott Rose, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2009
Diffuse laminar endocervical glandular hyperplasia: a case reportLouis A Dainty, Thomas C Krivak, Joel C Webb, et al.
Cancer|September 27, 2006
Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group studyG Larry Maxwell, Chunqiao Tian, John Risinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group StudyWilliam E Winter, G Larry Maxwell, Chunqiao Tian, et al.
Cancer Research|September 5, 2006
Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancerJan S Sunde, Howard Donninger, Kongming Wu, et al.
Pageof 7